| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.39B | +28.6% |
| Gross profit | ¥0.06B | — |
| Operating income | ¥0.01B | — |
| Net income | ¥0.00B | -83.6% |
| Gross margin | 14.1% | Net margin 1.1% |
| Revenue Q/Q | -15.4% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.34B | 85.9% |
| R&D | ¥0.02B | 4.7% |
| SG&A | ¥0.02B | 4.6% |
| Tax & other | ¥0.00B | 0.5% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
苏州规划 ・ 民生健康 ・ 中机认检 ・ 金凯生科 ・ 固高科技 ・ 德福科技 ・ 智信精密 ・ 尚水智能 ・ 港通医疗 ・ 中远通 ・ 陕西华达 ・ 长华化学
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies